Presentation Information

[S05-03]Development of LST antigen and its use as a surrogate marker for immunogenicity

Sreenivas Gannavaram1, Kamaleshwar P Singh2, Swarnendu Kaviraj2, Shinjiro Hamano3, Greg Matlashewski4, Hira L Nakhasi1, Sanjay Singh2, ○Abhay R Satoskar4,5 (1. Division of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA. (United States of America), 2. Gennova Biopharmaceuticals, Hinjawadi Phase II, Pune, Maharashtra, India, (India), 3. Department of Parasitology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan. The Joint Usage/Research Center on Tropical Disease, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan. (Japan), 4. Department of Microbiology and Immunology, McGill University, Montreal, Canada. (Canada), 5. Department of Pathology and Microbiology, Ohio State University, Columbus, OH, USA. (United States of America))

Password required to view


Comment

To browse or post comments, you must log in.Log in